Jeffrey A. Zonder

Statistics

Publications

119

Citations

10.2K

H-Index

Active since

1999

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

Wayne State University

Emory University

The University of Texas MD Anderson Cancer Center

Mayo Clinic in Arizona

Jeffrey A. Zonder is an author at The Barbara Ann Karmanos Cancer Institute specializing in medicine, multiple myeloma, and multiple myeloma treatment.

ORCID

Publications per year

1999–2024

119

Publications

119

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

S. Vincent Rajkumar, Jean‐Luc Harousseau, Brian G.M. Durie et al. · Blood · 2011 · 1K citations · Full text

Medicine, Hematology, Oncology +13

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis

Efstathios Kastritis, Giovanni Palladini, Monique C. Minnema et al. · New England Journal of Medicine · 2021 · 668 citations · Full text

Life Sciences, Hematology, Pharmacology +15

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

David S. Siegel, Thomas G. Martin, Michael Wang et al. · Blood · 2012 · 655 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Balloon kyphoplasty versus non-surgical fracture management for treatment of painful vertebral body compression fractures in patients with cancer: a multicentre, randomised controlled trial

James R. Berenson, Robert Pflugmacher, Peter Jarzem et al. · The Lancet Oncology · 2011 · 521 citations

Medicine, Oncology, Surgery +9

1–5 of 119